Amfenac sodium
- Level
- Commodity
- Parent
- 51383300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51383310This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PPF9V8J28Y. European Medicines Agency schedules Amfenac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00433MIG. Amfenac sodium generally arises in the molecular formula C15H12NO3.NA.H2O. The term 'amfenac sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule amfenac sodium under HS 29225000 and SITC 51467. As of Q4 2014, AMFENAC SODIUM remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)C(=O)C2CCCC(C2N)CC(=O)[O-].O.[NA+].
Same parent
Under 51383300 · 17Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.